Department of Family Medicine, Moi University School of Medicine, Eldoret, Kenya.
Academic Model Providing Access to Healthcare, Moi Teaching and Referral Hospital, Eldoret, Kenya.
Am J Trop Med Hyg. 2022 Jul 5;107(2):401-406. doi: 10.4269/ajtmh.22-0083. Print 2022 Aug 17.
Maternal syphilis remains a major contributor to poor pregnancy outcomes. Syphilis point-of-care (POC) tests are now used for pregnancy screening; the effect of screening on outcomes is unclear. We enrolled women presenting to antenatal care (ANC) in a matched cohort study at a single site in Kenya tested by either a syphilis-only or an HIV/syphilis dual POC test. Syphilis POC-positive women (patients) were matched 1:2 with POC-negative women (control subjects) on gravidity, gestational age, and HIV status, and were monitored through delivery. Syphilis serum testing was performed every 8 weeks. Pregnancy outcomes were assessed up to 1 month after delivery and compared using prevalence ratios. A total of 151 women were enrolled (51 patients and 100 control subjects) at a mean of 22 weeks gestation; 24% were HIV positive and 40% were paucigravid. A positive Treponema pallidum hemagglutination test was more common among patients (64.7%) than control subjects (11.1%, P < 0.001). Only two women met the definition for incident syphilis. Pregnancy outcomes were available for 147 women. The prevalence of low birthweight (LBW) was greater among patients (15.2%) than control subjects (5.4%, P = 0.052). Of the 109 women with concordant syphilis POC and Treponema pallidum hemagglutination test results at ANC enrollment, LBW prevalence was significantly greater among test-positive (25%) than test-negative (4.9%) women (adjusted prevalence ratio, 5.84; 95% CI, 1.08-31.5). Despite treatment with penicillin, latent syphilis at ANC enrollment was associated with a more than 5-fold increased risk of LBW. Alternate implementation strategies for syphilis POC testing may be necessary to realize the potential of ANC syphilis screening to improve pregnancy outcomes.
梅毒仍然是导致妊娠结局不良的主要原因之一。目前,梅毒即时检测(POC)已用于妊娠筛查;但筛查对结局的影响尚不清楚。我们在肯尼亚的一个单一地点,对参加产前保健(ANC)的女性进行了一项匹配队列研究,这些女性接受的检测要么是单纯梅毒 POC 检测,要么是 HIV/梅毒双重 POC 检测。梅毒 POC 阳性的女性(患者)与 POC 阴性的女性(对照)按照孕次、妊娠龄和 HIV 状态进行 1:2 匹配,并在分娩期间进行监测。每 8 周进行一次梅毒血清学检测。评估妊娠结局至分娩后 1 个月,并使用患病率比进行比较。共纳入 151 名女性(51 名患者和 100 名对照),平均妊娠龄为 22 周;24%的女性 HIV 阳性,40%的女性孕次较少。患者(64.7%)中 Treponema pallidum hemagglutination 试验阳性的比例高于对照(11.1%,P<0.001)。仅有两名女性符合新发梅毒的定义。147 名女性的妊娠结局数据可用。患者(15.2%)中低出生体重(LBW)的发生率高于对照(5.4%,P=0.052)。在 ANC 入组时梅毒 POC 和 Treponema pallidum hemagglutination 试验结果一致的 109 名女性中,试验阳性(25%)的 LBW 发生率显著高于试验阴性(4.9%)的女性(调整后的患病率比,5.84;95%CI,1.08-31.5)。尽管接受了青霉素治疗,但 ANC 入组时潜伏性梅毒与 LBW 风险增加 5 倍以上相关。可能需要采用替代的梅毒 POC 检测实施策略,才能实现 ANC 梅毒筛查改善妊娠结局的潜力。